Daejeon, South Korea

Jong Ha Park


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Minds of Jong Ha Park: Advancements in Wound Treatment

Introduction: Jong Ha Park, an accomplished inventor from Daejeon, South Korea, has made a significant contribution to the medical field through his innovative patent focused on wound dressing materials. With a keen interest in developing effective healing solutions, Park's work emphasizes the amalgamation of biocompatible materials for improved patient care.

Latest Patents: Jong Ha Park holds a patent for a unique wound dressing material that comprises a fibrillated acellular dermis matrix and a biodegradable polymer. His patent details a preparation method for a wound dressing that includes 5-20 wt % of a fibrillated acellular dermis matrix, 0.5-5 wt % of a biodegradable polymer, and 75-94.5 wt % of water. This innovation aims to enhance wound healing while ensuring compatibility with the human body.

Career Highlights: Throughout his career, Jong Ha Park has worked with notable companies such as Cg Bio Co., Ltd. and The Asan Foundation. His roles at these organizations have allowed him to apply his expertise in the development of innovative medical products, particularly in the realm of regenerative medicine.

Collaborations: In his journey of innovation, Jong Ha Park has collaborated with other talented individuals like Hee Jun Park and Hyun Seung Ryu. Their combined efforts have fostered a creative environment that promotes advanced solutions in the medical field, especially in wound care technologies.

Conclusion: Jong Ha Park stands as a testament to the importance of innovation in healthcare. His patented wound dressing material paves the way for enhanced healing processes, showcasing the potential of combining advanced materials for better medical solutions. As he continues to innovate, Jong Ha Park's contributions are sure to impact patient care positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…